Over-expression of the truncated ghrelin receptor polypeptide attenuates the constitutive activation of phosphatidylinositol-specific phospholipase C by ghrelin receptors but has no effect on ghrelin-stimulated extracellular signal-regulated kinase 1/2 activity

International Journal of Biochemistry and Cell Biology

Volumn 39, Issue 4, 2007, Pages 752-764

  Chu, Kit Man ^a   Chow, Kevin B S ^a   Leung, Po Ki ^a   Lau, Pui Ngan ^a   Chan, Chi Bun ^a   Cheng, Christopher H K ^a   Wise, Helen ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

ERK1 2; Ghrelin; Ghrelin receptors; GHS R1b

Indexed keywords

CONCANAVALIN A; GHRELIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHOLIPASE C; POLYPEPTIDE; SUBSTANCE P DERIVATIVE;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROLYSIS; KIDNEY CELL; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

BLOTTING, WESTERN; CELL LINE; CONCANAVALIN A; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCYTOSIS; ENZYME ACTIVATION; GENE EXPRESSION; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; OLIGOPEPTIDES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PEPTIDE HORMONES; PHOSPHATIDYLINOSITOL DIACYLGLYCEROL-LYASE; PHOSPHORYLATION; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, G-PROTEIN-COUPLED; SUBSTANCE P; TRANSFECTION;

EID: 33847716287     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2006.11.007     Document Type: Article

References (48)

1. Ahn S., Shenoy S.K., Wei H., and Lefkowitz R.J. Differential kinetic and spatial patterns of β-arrestin and G protein-mediated ERK activation by the angiotensin II receptor. Journal of Biological Chemistry 279 (2004) 35518-35525
2. Andreis P.G., Malendowicz L.K., Trejter M., Neri G., Spinazzi R., Rossi G.P., et al. Ghrelin and growth hormone secretagogue receptor are expressed in the rat adrenal cortex: Evidence that ghrelin stimulates the growth, but not the secretory activity of adrenal cells. FEBS Letters 536 (2003) 173-179
3. Barzon L., Pacenti M., Masi G., Stefani A.L., Fincati K., and Palù G. Loss of growth hormone secretagogue receptor 1a and overexpression of type 1b receptor transcripts in human adrenocortical tumors. Oncology 68 (2005) 414-421
4. Camiña J.P., Carreira M.C., Messari S.E., Llorens-Cortes C., Smith R.G., and Casanueva F.F. Desensitization and endocytosis mechanisms of ghrelin-activated growth hormone secretagogue receptor 1a. Endocrinology 145 (2004) 930-940
5. Camiña J.P. Cell biology of the ghrelin receptor. Journal of Neuroendocrinology 18 (2006) 65-76
6. Cao J.M., Ong H., and Chen C. Effects of ghrelin and synthetic GH secretagogues on the cardiovascular system. Trends in Endocrinology and Metabolism 17 (2006) 13-18
7. Chan C.B., and Cheng C.H.K. Identification and functional characterization of two alternatively spliced growth hormone secretagogue receptor transcripts from the pituitary of black seabream Acanthopagrus schlegeli. Molecular and Cellular Endocrinology 214 (2004) 81-95
8. Chan C.B., Leung P.K., Wise H., and Cheng C.H.K. Signal transduction mechanism of the seabream growth hormone secretagogue receptor. FEBS Letters 577 (2004) 147-153
9. Chow K.B.S., Wong Y.H., and Wise H. Prostacyclin receptor-independent inhibition of phospholipase C activity by non-prostanoid prostacyclin mimetics. British Journal of Pharmacology 134 (2001) 1375-1384
10. Cunha S.R., and Mayo K.E. Ghrelin and growth hormone (GH) secretagogues potentiate GH-releasing hormone (GHRH)-induced cyclic adenosine 3′,5′-monophosphate production in cells expressing transfected GHRH and GH secretagogue receptors. Endocrinology 143 (2002) 4570-4582
11. Daaka Y., Luttrell L.M., Ahn S., Della R.G., Ferguson S.S., Caron M.G., et al. Essential role for G protein-coupled receptor endocytosis in the activation of mitogen-activated protein kinase. Journal of Biological Chemistry 273 (1998) 685-688
12. Davenport A.P., Bonner T.I., Foord S.M., Harmar A.J., Neubig R.R., Pin J.P., et al. International Union of Pharmacology. LVI. Ghrelin receptor nomenclature, distribution, and function. Pharmacological Reviews 57 (2005) 541-546
13. Duxbury M.S., Waseem T., Ito H., Robinson M.K., Zinner M.J., Ashley S.W., et al. Ghrelin promotes pancreatic and adenocarcinoma cellular proliferation and invasiveness. Biochemical and Biophysical Research Communications 309 (2003) 464-468
14. Gao Y., Tang S., Zhou S., and Ware J.A. The thromboxane A2 receptor activates mitogen-activated protein kinase via protein kinase C-dependent Gi coupling and src-dependent phosphorylation of the epidermal growth factor receptor. Journal of Pharmacology and Experimental Therapeutics 296 (2001) 426-433
15. Garcia A., Alvarez C.V., Smith R.G., and Dieguez C. Regulation of PIT-1 expression by ghrelin and GHRP-6 through the GH secretagogue receptor. Molecular Endocrinology 15 (2001) 1484-1495
16. 2 is prevented by phosphatidylcholine-specific phospholipase C inhibitor tricyclodecan-9-yl-xanthate (D609). Journal of Pharmacology and Experimental Therapeutics 301 (2002) 87-94
17. Gnanapavan S., Kola B., Bustin S.A., Morris D.G., McGee P., Fairclough P., et al. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. Journal of Clinical Endocrinology and Metabolism 87 (2002) 2988-2991
18. Gutkind J.S. The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades. Journal of Biological Chemistry 273 (1998) 1839-1842
19. Holst B., Brandt E., Bach A., Heding A., and Schwartz T.W. Nonpeptide and peptide growth hormone secretagogues act both as ghrelin receptor agonist and as positive or negative allosteric modulators of ghrelin signaling. Molecular Endocrinology 19 (2005) 2400-2411
20. Holst B., Cygankiewicz A., Jensen T.H., Ankersen M., and Schwartz T.W. High constitutive signalling of the ghrelin receptor-Identification of a potent inverse agonist. Molecular Endocrinology 17 (2003) 2201-2210
21. Holst B., Holliday N.D., Bach A., Elling C.E., Cox H.M., and Schwartz T.W. Common structural basis for constitutive activity of the ghrelin receptor family. Journal of Biological Chemistry 279 (2004) 53806-53817
22. Holst B., and Schwartz T.W. Ghrelin receptor mutations-Too little height and too much hunger. Journal of Clinical Investigation 116 (2006) 637-641
23. Howard A.D., Feighner S.D., Cully D.F., Arena J.P., Liberator P.A., Rosenblum C.I., et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273 (1996) 974-977
24. Jeffery P.L., Herington A.C., and Chopin L.K. The potential autocrine/paracrine roles of ghrelin and its receptor in hormone-dependent cancer. Cytokine & Growth Factor Reviews 14 (2003) 113-122
25. Kim M.S., Yoon C.Y., Jang P.G., Park Y.J., Shin C.S., Park H.S., et al. The mitogenic and anti-apoptotic actions of ghrelin in 3T3-L1 adipocytes. Molecular Endocrinology 18 (2004) 2291-2301
26. Kim S.W., Her S.J., Park S.J., Kim D., Park K.S., Lee H.Y., et al. Ghrelin stimulates proliferation and differentiation and inhibits apoptosis in osteoblastic MC3T3-E1 cells. Bone 37 (2005) 359-369
27. Krupnick J.G., Santini F., Gagnon A.W., Keen J.H., and Benovic J.L. Modulation of the arrestin-clathrin interaction in cells. Journal of Biological Chemistry 272 (1997) 32507-32512
28. Lee S.C., Han J.S., Seo J.K., and Cha Y.N. Modulation of cyclooxygenase-2 expression by phosphatidylcholine specific phospholipase C and D in macrophages stimulated with lipopolysaccharide. Molecular Cell 15 (2003) 320-326
29. Lefkowitz R.J., and Shenoy S.K. Transduction of receptor signals by β-arrestins. Science 308 (2005) 512-517
30. Lefkowitz R.J., and Whalen E.J. β-Arrestins: Traffic cops of cell signaling. Current Opinion in Cell Biology 16 (2004) 162-168
31. Marion S., Oakley R.H., Kim K.M., Caron M.G., and Barak L.S. A β-arrestin binding determinant common to the second intracellular loops of rhodopsin family G protein-coupled receptors. Journal of Biological Chemistry 281 (2006) 2932-2938
32. McKee K.K., Palyha O.C., Feighner S.D., Hreniuk D.L., Tan C.P., Phillips M.S., et al. Molecular analysis of rat pituitary and hypothalamic growth hormone secretagogue receptors. Molecular Endocrinology 11 (1997) 415-423
33. Mousseaux D., Le Gallic L., Ryan J., Oiry C., Gagne D., Fehrentz J.-A., et al. Regulation of ERK1/2 activity by ghrelin-activated growth hormone secretagogue receptor 1A involves a PLC/PKCε pathway. British Journal of Pharmacology 148 (2006) 350-365
34. Müller-Decker K. Interruption of TPA-induced signals by an antiviral and antitumoral xanthate compound: Inhibition of a phospholipase C-type reaction. Biochemical and Biophysical Research Communications 162 (1989) 198-205
35. Murata M., Okimura Y., Iida K., Matsumoto M., Sowa H., Kaji H., et al. Ghrelin modulates the downstream molecules of insulin signaling in hepatoma cells. Journal of Biological Chemistry 277 (2002) 5667-5674
36. Nanzer A.M., Khalaf S., Mozid A.M., Fowkes R.C., Patel M.V., Burrin J.M., et al. Ghrelin exerts a proliferative effect on a rat pituitary somatotroph cell line via the mitogen-activated protein kinase pathway. European Journal of Endocrinology 151 (2004) 233-240
37. Neary J.T., Kang Y., Bu Y., Yu E., Akong K., and Peters C.M. Mitogenic signaling by ATP/P2Y purinergic receptors in astrocytes: Involvement of a calcium-independent protein kinase C, extracellular signal-regulated protein kinase pathway distinct from the phosphatidylinositol-specific phospholipase C/calcium pathway. Journal of Neuroscience 19 (1999) 4211-4220
38. 2 receptor α and β isoforms. Journal of Biological Chemistry 274 (1999) 8941-8948
39. Pettitt T.R., Martin A., Horton T., Liossis C., Lord J.M., and Wakelam M.J.O. Diacylglycerol and phosphatidate generated by phospholipases C and D, respectively, have distinct fatty acid compositions and functions. Journal of Biological Chemistry 272 (1997) 17354-17359
40. 2-adrenergic receptors permit receptor resensitization. Molecular Pharmacology 47 (1995) 6666-6676
41. Smith R.G., Feighner S., Prendergast K., Guan X., and Howard A. A new orphan receptor involved in pulsatile growth hormone release. Trends in Endocrinology and Metabolism 10 (1999) 128-135
42. Sohn U.D., Harnett K.M., Cao W., Rich H., Kim N., Behar J., et al. Acute experimental esophagitis activates a second signal transduction pathway in cat smooth muscle from the lower esophageal sphincter. Journal of Pharmacology and Experimental Therapeutics 283 (1997) 1293-1304
43. Terrillon S., and Bouvier M. Receptor activity-independent recruitment of βarrestin2 reveals specific signalling modes. EMBO Journal 23 (2004) 3950-3961
44. Tullin S., Hansen B.S., Ankersen M., Møller J., Von Cappelen K.A., and Thim L. Adenosine is an agonist of the growth hormone secretagogue receptor. Endocrinology 141 (2000) 3397-3402
45. van Dijk M.C.M., Muriana F.J.G., de Widt J., Hilkmann H., and van Blitterwijk W.J. Involvement of phosphatidylcholine-specific phospholipase C in platelet-derived growth factor-induced activation of the mitogen-activated protein kinase pathway in Rat-1 fibroblasts. Journal of Biological Chemistry 272 (1997) 11011-11016
46. van der Lely A.J., Tschop M., Heiman M.L., and Ghigo E. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocrine Reviews 25 (2004) 426-457
47. Werry T.D., Sexton P.M., and Christopoulos A. 'Ins and outs' of seven-transmembrane receptor signalling to ERK. Trends in Endocrinology and Metabolism 16 (2005) 26-33
48. 2 receptors: Site-directed mutagenesis reveals the significance of the isoleucine residue at position 323. Journal of Receptors and Signal Transduction 23 (2003) 83-97